title: Pramipexole reduces phosphorylation of α-synuclein at serine-129.
abstract: α-Synuclein is a central component of the pathogenesis of Parkinson's disease (PD). Phosphorylation at serine-129 represents an important post-translational modification and constitutes the major form of the protein in Lewy bodies. Several kinases have been implicated in the phosphorylation of α-synuclein. The targeting of kinase pathways as a potential to influence the pathogenesis of PD is an important focus of attention, given that mutations of specific kinases (LRRK2 and PINK1) are causes of familial PD. Pramipexole (PPX) is a dopamine agonist developed for the symptomatic relief of PD. Several in vitro and in vivo laboratory studies have demonstrated that PPX exerts neuroprotective properties in model systems of relevance to PD. The present study demonstrates that PPX inhibits the phosphorylation of α-synuclein and that this is independent of dopamine receptor activation. PPX blocks the increase in phosphorylated α-synuclein induced by inhibition of the ubiquitin proteasomal system. The phosphorylation of α-synuclein occurs in part at least through casein kinase 2, and PPX in turn reduces the phosphorylation of this enzyme, thereby inhibiting its activity. Thus, PPX decreases the phosphorylation of α-synuclein, and this mechanism may contribute to its protective properties in PD models.
authors.affiliation: Department of Clinical Neurosciences, Institute of Neurology, University College London, Rowland Hill Street, London, NW3 2PF, UK.
authors.forename: Kai-Yin
authors.initials: KY
authors.lastname: Chau
authors.forename: J Mark
authors.initials: JM
authors.lastname: Cooper
authors.forename: Anthony Henry V
authors.initials: AH
authors.lastname: Schapira
mesh_terms: D000978:Antiparkinson Agents / Q000494:pharmacology*; D052160:Benzothiazoles / Q000494:pharmacology*; D047390:Casein Kinase II / Q000378:metabolism; D045744:Cell Line, Tumor; D006801:Humans; D010766:Phosphorylation / Q000187:drug effects; D000077487:Pramipexole; D012694:Serine / Q000378:metabolism; D051844:alpha-Synuclein / Q000378:metabolism*
chemical_list: D000978:Antiparkinson Agents; D052160:Benzothiazoles; D051844:alpha-Synuclein; D012694:Serine; D000077487:Pramipexole; D047390:Casein Kinase II